---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-000922"
form_type: "8-K"
ticker: "CODX"
cik: "0001692415"
company_name: "Co-Diagnostics, Inc."
filed_at: "2025-03-27T23:59:59+00:00"
generated_at: "2026-05-24T03:57:28.316716+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Co-Diagnostics FY2024 revenue $3.9M, net loss $37.6M; withdraws 510(k) for platform

## Summary
- Revenue $3.9M vs $6.8M in 2023; product revenue $0.8M, grant revenue $3.1M.
- Net loss $37.6M ($1.24/diluted share) vs $35.3M ($1.20) prior year.
- Adjusted EBITDA loss of $33.5M; operating expenses $43.0M decreased 5.2% YoY.
- Cash and marketable securities $29.7M as of Dec 31, 2024.
- Withdrew initial 510(k) for Co-Dx PCR Pro; plans to resubmit enhanced version.

## SEC filing metadata
- accession: 0001641172-25-000922
- form_type: 8-K
- ticker: CODX
- cik: 0001692415
- company_name: Co-Diagnostics, Inc.
- filed_at: 2025-03-27T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1692415/000164117225000922/0001641172-25-000922-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1692415/000164117225000922/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-000922
- JSON: https://secwatch.observer/filing/0001641172-25-000922.json
- Plain text: https://secwatch.observer/filing/0001641172-25-000922.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.